Selected research
Industry Research
Process Development and Scale-up Services Industry Research Report 2026
Market perspective
The global Process Development and Scale-up Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Process Development and Scale-up Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Process Development and Scale-up Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Process Development and Scale-up Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Process Development and Scale-up Services include Thermo Fisher Scientific Inc, Wuxi Biologics, Applus+ Laboratories, Scinai Immunotherapeutics, Fraserna, Suzhou Intellective Bio, Shanghai ChemPartner, TOT BIOPHARM and Molefuture (Yeasen), among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Process Development and Scale-up Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Process Development and Scale-up Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Process Development and Scale-up Services Market by Company
Thermo Fisher Scientific Inc
Wuxi Biologics
Applus+ Laboratories
Scinai Immunotherapeutics
Fraserna
Suzhou Intellective Bio
Shanghai ChemPartner
TOT BIOPHARM
Molefuture (Yeasen)
BioDuro-Sundia
Shenzhen Pregene Biopharma Co., Ltd
ScaleUp Bio Pte Ltd
BRAIN Biotech AG
Kemitek
Charles River
Actylis
Sai Life Sciences
InChem Corporation
Nalas Engineering Services
NUVISAN
Nalas Engineering Services Inc
SPERA PHARMA
Creative Biolabs
Phosphorex, LLC
3xper Innoventure
Lianhetech
Jiangsu Yaohaibio
Bellenchem
Process Development and Scale-up Services Segment by Type
Fine Chemical Development and Scale-up
Biopharmaceutical Development and Scale-up
Others
Process Development and Scale-up Services Segment by Application
SMEs
Large Enterprises
Process Development and Scale-up Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Process Development and Scale-up Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Process Development and Scale-up Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Process Development and Scale-up Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Process Development and Scale-up Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Fine Chemical Development and Scale-up
- Biopharmaceutical Development and Scale-up
- Others
Applications
- SMEs
- Large Enterprises
Companies covered
- Thermo Fisher Scientific Inc
- Wuxi Biologics
- Applus+ Laboratories
- Scinai Immunotherapeutics
- Fraserna
- Suzhou Intellective Bio
- Shanghai ChemPartner
- TOT BIOPHARM
- Molefuture (Yeasen)
- BioDuro-Sundia
- Shenzhen Pregene Biopharma Co., Ltd
- ScaleUp Bio Pte Ltd
- BRAIN Biotech AG
- Kemitek
- Charles River
- Actylis
- Sai Life Sciences
- InChem Corporation
- Nalas Engineering Services
- NUVISAN
- Nalas Engineering Services Inc
- SPERA PHARMA
- Creative Biolabs
- Phosphorex, LLC
- 3xper Innoventure
- Lianhetech
- Jiangsu Yaohaibio
- Bellenchem
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Process Development and Scale-up Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Fine Chemical Development and Scale-up
- 2.2.3 Biopharmaceutical Development and Scale-up
- 2.2.4 Others
- 2.3 Process Development and Scale-up Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 SMEs
- 2.3.3 Large Enterprises
- 2.4 Assumptions and Limitations
3 Process Development and Scale-up Services Breakdown Data by Type
- 3.1 Global Process Development and Scale-up Services Historic Market Size by Type (2021-2026)
- 3.2 Global Process Development and Scale-up Services Forecasted Market Size by Type (2027-2032)
4 Process Development and Scale-up Services Breakdown Data by Application
- 4.1 Global Process Development and Scale-up Services Historic Market Size by Application (2021-2026)
- 4.2 Global Process Development and Scale-up Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Process Development and Scale-up Services Market Perspective (2021-2032)
- 5.2 Global Process Development and Scale-up Services Growth Trends by Region
- 5.2.1 Global Process Development and Scale-up Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Process Development and Scale-up Services Historic Market Size by Region (2021-2026)
- 5.2.3 Process Development and Scale-up Services Forecasted Market Size by Region (2027-2032)
- 5.3 Process Development and Scale-up Services Market Dynamics
- 5.3.1 Process Development and Scale-up Services Industry Trends
- 5.3.2 Process Development and Scale-up Services Market Drivers
- 5.3.3 Process Development and Scale-up Services Market Challenges
- 5.3.4 Process Development and Scale-up Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Process Development and Scale-up Services Players by Revenue
- 6.1.1 Global Top Process Development and Scale-up Services Players by Revenue (2021-2026)
- 6.1.2 Global Process Development and Scale-up Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Process Development and Scale-up Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Process Development and Scale-up Services Head Office and Area Served
- 6.4 Global Process Development and Scale-up Services Players, Product Type & Application
- 6.5 Global Process Development and Scale-up Services Manufacturers Established Date
- 6.6 Global Process Development and Scale-up Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Process Development and Scale-up Services Market Size (2021-2032)
- 7.2 North America Process Development and Scale-up Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Process Development and Scale-up Services Market Size by Country (2021-2026)
- 7.4 North America Process Development and Scale-up Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Process Development and Scale-up Services Market Size (2021-2032)
- 8.2 Europe Process Development and Scale-up Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Process Development and Scale-up Services Market Size by Country (2021-2026)
- 8.4 Europe Process Development and Scale-up Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Process Development and Scale-up Services Market Size (2021-2032)
- 9.2 Asia-Pacific Process Development and Scale-up Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Process Development and Scale-up Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Process Development and Scale-up Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Process Development and Scale-up Services Market Size (2021-2032)
- 10.2 South America Process Development and Scale-up Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Process Development and Scale-up Services Market Size by Country (2021-2026)
- 10.4 South America Process Development and Scale-up Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Process Development and Scale-up Services Market Size (2021-2032)
- 11.2 Middle East & Africa Process Development and Scale-up Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Process Development and Scale-up Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Process Development and Scale-up Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher Scientific Inc
- 12.1.1 Thermo Fisher Scientific Inc Company Information
- 12.1.2 Thermo Fisher Scientific Inc Business Overview
- 12.1.3 Thermo Fisher Scientific Inc Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.1.4 Thermo Fisher Scientific Inc Process Development and Scale-up Services Product Portfolio
- 12.1.5 Thermo Fisher Scientific Inc Recent Developments
- 12.2 Wuxi Biologics
- 12.2.1 Wuxi Biologics Company Information
- 12.2.2 Wuxi Biologics Business Overview
- 12.2.3 Wuxi Biologics Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.2.4 Wuxi Biologics Process Development and Scale-up Services Product Portfolio
- 12.2.5 Wuxi Biologics Recent Developments
- 12.3 Applus+ Laboratories
- 12.3.1 Applus+ Laboratories Company Information
- 12.3.2 Applus+ Laboratories Business Overview
- 12.3.3 Applus+ Laboratories Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.3.4 Applus+ Laboratories Process Development and Scale-up Services Product Portfolio
- 12.3.5 Applus+ Laboratories Recent Developments
- 12.4 Scinai Immunotherapeutics
- 12.4.1 Scinai Immunotherapeutics Company Information
- 12.4.2 Scinai Immunotherapeutics Business Overview
- 12.4.3 Scinai Immunotherapeutics Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.4.4 Scinai Immunotherapeutics Process Development and Scale-up Services Product Portfolio
- 12.4.5 Scinai Immunotherapeutics Recent Developments
- 12.5 Fraserna
- 12.5.1 Fraserna Company Information
- 12.5.2 Fraserna Business Overview
- 12.5.3 Fraserna Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.5.4 Fraserna Process Development and Scale-up Services Product Portfolio
- 12.5.5 Fraserna Recent Developments
- 12.6 Suzhou Intellective Bio
- 12.6.1 Suzhou Intellective Bio Company Information
- 12.6.2 Suzhou Intellective Bio Business Overview
- 12.6.3 Suzhou Intellective Bio Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.6.4 Suzhou Intellective Bio Process Development and Scale-up Services Product Portfolio
- 12.6.5 Suzhou Intellective Bio Recent Developments
- 12.7 Shanghai ChemPartner
- 12.7.1 Shanghai ChemPartner Company Information
- 12.7.2 Shanghai ChemPartner Business Overview
- 12.7.3 Shanghai ChemPartner Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.7.4 Shanghai ChemPartner Process Development and Scale-up Services Product Portfolio
- 12.7.5 Shanghai ChemPartner Recent Developments
- 12.8 TOT BIOPHARM
- 12.8.1 TOT BIOPHARM Company Information
- 12.8.2 TOT BIOPHARM Business Overview
- 12.8.3 TOT BIOPHARM Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.8.4 TOT BIOPHARM Process Development and Scale-up Services Product Portfolio
- 12.8.5 TOT BIOPHARM Recent Developments
- 12.9 Molefuture (Yeasen)
- 12.9.1 Molefuture (Yeasen) Company Information
- 12.9.2 Molefuture (Yeasen) Business Overview
- 12.9.3 Molefuture (Yeasen) Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.9.4 Molefuture (Yeasen) Process Development and Scale-up Services Product Portfolio
- 12.9.5 Molefuture (Yeasen) Recent Developments
- 12.10 BioDuro-Sundia
- 12.10.1 BioDuro-Sundia Company Information
- 12.10.2 BioDuro-Sundia Business Overview
- 12.10.3 BioDuro-Sundia Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.10.4 BioDuro-Sundia Process Development and Scale-up Services Product Portfolio
- 12.10.5 BioDuro-Sundia Recent Developments
- 12.11 Shenzhen Pregene Biopharma Co., Ltd
- 12.11.1 Shenzhen Pregene Biopharma Co., Ltd Company Information
- 12.11.2 Shenzhen Pregene Biopharma Co., Ltd Business Overview
- 12.11.3 Shenzhen Pregene Biopharma Co., Ltd Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.11.4 Shenzhen Pregene Biopharma Co., Ltd Process Development and Scale-up Services Product Portfolio
- 12.11.5 Shenzhen Pregene Biopharma Co., Ltd Recent Developments
- 12.12 ScaleUp Bio Pte Ltd
- 12.12.1 ScaleUp Bio Pte Ltd Company Information
- 12.12.2 ScaleUp Bio Pte Ltd Business Overview
- 12.12.3 ScaleUp Bio Pte Ltd Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.12.4 ScaleUp Bio Pte Ltd Process Development and Scale-up Services Product Portfolio
- 12.12.5 ScaleUp Bio Pte Ltd Recent Developments
- 12.13 BRAIN Biotech AG
- 12.13.1 BRAIN Biotech AG Company Information
- 12.13.2 BRAIN Biotech AG Business Overview
- 12.13.3 BRAIN Biotech AG Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.13.4 BRAIN Biotech AG Process Development and Scale-up Services Product Portfolio
- 12.13.5 BRAIN Biotech AG Recent Developments
- 12.14 Kemitek
- 12.14.1 Kemitek Company Information
- 12.14.2 Kemitek Business Overview
- 12.14.3 Kemitek Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.14.4 Kemitek Process Development and Scale-up Services Product Portfolio
- 12.14.5 Kemitek Recent Developments
- 12.15 Charles River
- 12.15.1 Charles River Company Information
- 12.15.2 Charles River Business Overview
- 12.15.3 Charles River Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.15.4 Charles River Process Development and Scale-up Services Product Portfolio
- 12.15.5 Charles River Recent Developments
- 12.16 Actylis
- 12.16.1 Actylis Company Information
- 12.16.2 Actylis Business Overview
- 12.16.3 Actylis Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.16.4 Actylis Process Development and Scale-up Services Product Portfolio
- 12.16.5 Actylis Recent Developments
- 12.17 Sai Life Sciences
- 12.17.1 Sai Life Sciences Company Information
- 12.17.2 Sai Life Sciences Business Overview
- 12.17.3 Sai Life Sciences Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.17.4 Sai Life Sciences Process Development and Scale-up Services Product Portfolio
- 12.17.5 Sai Life Sciences Recent Developments
- 12.18 InChem Corporation
- 12.18.1 InChem Corporation Company Information
- 12.18.2 InChem Corporation Business Overview
- 12.18.3 InChem Corporation Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.18.4 InChem Corporation Process Development and Scale-up Services Product Portfolio
- 12.18.5 InChem Corporation Recent Developments
- 12.19 Nalas Engineering Services
- 12.19.1 Nalas Engineering Services Company Information
- 12.19.2 Nalas Engineering Services Business Overview
- 12.19.3 Nalas Engineering Services Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.19.4 Nalas Engineering Services Process Development and Scale-up Services Product Portfolio
- 12.19.5 Nalas Engineering Services Recent Developments
- 12.20 NUVISAN
- 12.20.1 NUVISAN Company Information
- 12.20.2 NUVISAN Business Overview
- 12.20.3 NUVISAN Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.20.4 NUVISAN Process Development and Scale-up Services Product Portfolio
- 12.20.5 NUVISAN Recent Developments
- 12.21 Nalas Engineering Services Inc
- 12.21.1 Nalas Engineering Services Inc Company Information
- 12.21.2 Nalas Engineering Services Inc Business Overview
- 12.21.3 Nalas Engineering Services Inc Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.21.4 Nalas Engineering Services Inc Process Development and Scale-up Services Product Portfolio
- 12.21.5 Nalas Engineering Services Inc Recent Developments
- 12.22 SPERA PHARMA
- 12.22.1 SPERA PHARMA Company Information
- 12.22.2 SPERA PHARMA Business Overview
- 12.22.3 SPERA PHARMA Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.22.4 SPERA PHARMA Process Development and Scale-up Services Product Portfolio
- 12.22.5 SPERA PHARMA Recent Developments
- 12.23 Creative Biolabs
- 12.23.1 Creative Biolabs Company Information
- 12.23.2 Creative Biolabs Business Overview
- 12.23.3 Creative Biolabs Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.23.4 Creative Biolabs Process Development and Scale-up Services Product Portfolio
- 12.23.5 Creative Biolabs Recent Developments
- 12.24 Phosphorex, LLC
- 12.24.1 Phosphorex, LLC Company Information
- 12.24.2 Phosphorex, LLC Business Overview
- 12.24.3 Phosphorex, LLC Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.24.4 Phosphorex, LLC Process Development and Scale-up Services Product Portfolio
- 12.24.5 Phosphorex, LLC Recent Developments
- 12.25 3xper Innoventure
- 12.25.1 3xper Innoventure Company Information
- 12.25.2 3xper Innoventure Business Overview
- 12.25.3 3xper Innoventure Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.25.4 3xper Innoventure Process Development and Scale-up Services Product Portfolio
- 12.25.5 3xper Innoventure Recent Developments
- 12.26 Lianhetech
- 12.26.1 Lianhetech Company Information
- 12.26.2 Lianhetech Business Overview
- 12.26.3 Lianhetech Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.26.4 Lianhetech Process Development and Scale-up Services Product Portfolio
- 12.26.5 Lianhetech Recent Developments
- 12.27 Jiangsu Yaohaibio
- 12.27.1 Jiangsu Yaohaibio Company Information
- 12.27.2 Jiangsu Yaohaibio Business Overview
- 12.27.3 Jiangsu Yaohaibio Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.27.4 Jiangsu Yaohaibio Process Development and Scale-up Services Product Portfolio
- 12.27.5 Jiangsu Yaohaibio Recent Developments
- 12.28 Bellenchem
- 12.28.1 Bellenchem Company Information
- 12.28.2 Bellenchem Business Overview
- 12.28.3 Bellenchem Revenue in Process Development and Scale-up Services Business (2021-2026)
- 12.28.4 Bellenchem Process Development and Scale-up Services Product Portfolio
- 12.28.5 Bellenchem Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst